Diversify Advisory Services LLC trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 16.3% during the ...
Zacks Research boosted their Q2 2025 earnings per share estimates for Gilead Sciences in a report issued on Thursday, January ...
Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...
Global leaders must urgently prioritise and work to provide access to new long-acting HIV prevention -- and potentially ...
Co-founder Finny Kuruvilla manages the firm’s largest two funds — Eventide Gilead and Eventide Healthcare and Life Sciences — and remains the firm’s largest owner, though more than 20 of ...
allAfrica.com on MSN5d
Africa: UNAIDS Calls On Leaders At Davos To Commit To Rapid Global Access To Revolutionary New Long-Acting HIV MedicinesUNAIDS urges speed and compassion urging pharmaceutical companies to enable access to new, life-saving medicines ...
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...
Local AIDS experts are at odds with the United Nations Programme on HIV/AIDS (UNAIDS) over its claims that AIDS could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback